These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
72 related articles for article (PubMed ID: 2382439)
1. [Recovery of the anticoagulation system function in patients with insulin-dependent diabetes by neutralization of the activity of diabetogenic factor]. Kudriashov BA; Balabolkin MI; Ul'ianov AM; Liapina LA; Levitskaia ZI Vopr Med Khim; 1990; 36(3):79-81. PubMed ID: 2382439 [TBL] [Abstract][Full Text] [Related]
2. [Complex-formation of heparin with the plasma diabetogenic factor]. Kudriashov BA; Liapina LA Vopr Med Khim; 1986; 32(2):64-5. PubMed ID: 3705518 [TBL] [Abstract][Full Text] [Related]
3. [C-peptide, diabetogenic factor and the blood anticoagulating system in patients with the insulin-dependent type of diabetes mellitus before and after heparin therapy]. Balabolkin MI; Kudriashov BA; Levitskaia ZI; Liapina LA; Ul'ianov AM Probl Endokrinol (Mosk); 1990; 36(1):25-8. PubMed ID: 2330356 [TBL] [Abstract][Full Text] [Related]
4. [The role of endogenous heparin in the protection against risk factors causing experimental diabetes]. Kudriashov BA; Ul'ianov AM; Tarasov IuA Vopr Med Khim; 1989; 35(6):80-2. PubMed ID: 2629244 [TBL] [Abstract][Full Text] [Related]
5. [Role of the diabetogenic factor in hypercoagulation of the blood]. Kudriashov BA; Liapina LA; Ul'ianov AM Fiziol Zh SSSR Im I M Sechenova; 1986 Mar; 72(3):373-6. PubMed ID: 3709867 [TBL] [Abstract][Full Text] [Related]
7. [Changes in the diabetogenic factor activity in the blood plasma of children with diabetes mellitus resulting from systematic heparin administration]. Kudriashov BA; Zhukovskiĭ MA; Shcherbacheva LN; Ul'ianov AM; Bazaz'ian GG Pediatriia; 1985 Aug; (8):46-7. PubMed ID: 4069883 [No Abstract] [Full Text] [Related]
8. [Isolation and various physico-chemical properties of diabetogenic factor from the blood of patients with diabetes]. Kudriashov BA; Liapina LA; Azieva LD Vopr Med Khim; 1989; 35(6):63-6. PubMed ID: 2629241 [TBL] [Abstract][Full Text] [Related]
9. [Functional changes in the state of the insular system of animals after intravenous administration of diabetogenic factor]. Kudriashov BA; Ul'ianov AM; Liapina LA Vopr Med Khim; 1986; 32(5):57-9. PubMed ID: 3535246 [TBL] [Abstract][Full Text] [Related]
10. [Dependence of the blood plasma activity of the diabetogenic factor in animals on the functional depression of the anticoagulating system induced by an atherogenic diet]. Kudriashov BA; Ul'ianov AM; Bazaz'ian GG Nauchnye Doki Vyss Shkoly Biol Nauki; 1986; (2):50-3. PubMed ID: 3697425 [TBL] [Abstract][Full Text] [Related]
11. [The toxic action of the "diabetogenic factor" metabolite in the body during the development of insulin-dependent diabetes]. Kudriashov BA Izv Akad Nauk Ser Biol; 1993; (5):694-702. PubMed ID: 8220079 [TBL] [Abstract][Full Text] [Related]
12. [Role of the diabetogenic factor in the activation of the blood coagulation system in experimental alloxan diabetes]. Kudriashov BA; Ul'ianov AM; Liapina LA Patol Fiziol Eksp Ter; 1986; (4):44-7. PubMed ID: 3797076 [No Abstract] [Full Text] [Related]
13. [Stable reduction of endogenous insulin production in the body in experimental insulin-dependent diabetes]. Kudriashov BA; Ul'ianov AM Vopr Med Khim; 1991; 37(4):40-3. PubMed ID: 1750208 [TBL] [Abstract][Full Text] [Related]
14. [Correction of the disturbed coagulation circadian rhythm in patients with type 1 diabetes mellitus treated by aspirin chronotherapy]. Zaslavskaia RM; Tulemisov EU Klin Med (Mosk); 2008; 86(10):17-23. PubMed ID: 19069453 [TBL] [Abstract][Full Text] [Related]
15. In vivo and in vitro evaluation of the heparin management test versus the activated coagulation time for monitoring anticoagulation level in aprotinin-treated patients during cardiac surgery. Kim YS; Murkin JM; Adams SJ Heart Surg Forum; 2004; 7(6):E599-604. PubMed ID: 15769695 [TBL] [Abstract][Full Text] [Related]
16. Hormonal counterregulation during severe hypoglycaemia under everyday conditions in patients with type 1 and insulin-treated type 2 diabetes mellitus. Holstein A; Hammer C; Plaschke A; Ptak M; Kuhn J; Diekmann J; Kleesiek K; Egberts EH Exp Clin Endocrinol Diabetes; 2004 Sep; 112(8):429-34. PubMed ID: 15372362 [TBL] [Abstract][Full Text] [Related]
17. Vascular endothelial growth factor during hypoglycemia in patients with type 1 diabetes mellitus: relation to cognitive function and renin-angiotensin system activity. Kristensen PL; Høi-Hansen T; Boomsma F; Pedersen-Bjergaard U; Thorsteinsson B Metabolism; 2009 Oct; 58(10):1430-8. PubMed ID: 19573885 [TBL] [Abstract][Full Text] [Related]
18. [Effect of delagil on the blood coagulation system and the interrelation with heparin]. Ovchinnikova LK; Pomortseva IV Farmakol Toksikol; 1985; 48(2):77-81. PubMed ID: 3996575 [TBL] [Abstract][Full Text] [Related]
19. [Heparin level and coagulation potential after subcutaneous injection of 7500 international units of heparin calcium]. Briel RC Dtsch Med Wochenschr; 1984 Jun; 109(25):993-6. PubMed ID: 6734457 [TBL] [Abstract][Full Text] [Related]
20. [The role of some pituitary hormones in patients with non-insulin-dependent diabetes mellitus and diabetic retinopathy]. Dundua TT; Sumbadze TsM; Dzhodzhua TD; Papava MV Georgian Med News; 2006 Aug; (137):68-71. PubMed ID: 16980749 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]